Question [Regulatives / Guidelines]

posted by AngusMcLean – USA, 2014-12-10 19:34 (4214 d 02:08 ago) – Posting: # 14050
Views: 16,622

ANA is the GURU:

SEE HER EMAIL

G(2,2) = sig_BR^2 = lambda(2,1)^2+lambda(2,2)^2

G(1,2) = rho*sig_BT*sig_BR = lambda(1,1)*lambda(2,1) (= between subject covariance for test and reference)

THE SIGMA SQUARED D calculation is shown in one of my posts from yesterday. The co variate term is subtracted from the sum of the other two parameters.

From Helmut's post above to the European document the following narrative is obtained.

This model allows a different subject effect for each formulation (i.e. a subject by formulation interaction), and therefore has 5 variance terms:


(1) Within subject for reference
(2) Within Subject for Test
(3) Between Subject for Test
(4) Between Subject for Reference
(5) Covariance for between subject test and reference

It also states the last three are "combined" to give the subject ×formulation interaction variance component.

From Ana’s letter the "combination" involves the addition of (3+4)-5.
Thread locked

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
142 visitors (0 registered, 142 guests [including 33 identified bots]).
Forum time: 22:43 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5